Trudy Morrison to Humans
This is a "connection" page, showing publications Trudy Morrison has written about Humans.
Connection Strength
0.265
-
Blanco JCG, Cullen LM, Kamali A, Sylla FYD, Boukhvalova MS, Morrison TG. Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly. Viruses. 2023 05 31; 15(6).
Score: 0.033
-
McGinnes Cullen L, Luo B, Wen Z, Zhang L, Durr E, Morrison TG. The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate. J Virol. 2023 01 31; 97(1):e0190022.
Score: 0.032
-
Blanco JCG, Fernando LR, Zhang W, Kamali A, Boukhvalova MS, McGinnes-Cullen L, Morrison TG. Alternative Virus-Like Particle-Associated Prefusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus. J Virol. 2019 12 01; 93(23).
Score: 0.026
-
McGinnes Cullen L, Schmidt MR, Morrison TG. Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles. J Virol. 2019 05 01; 93(9).
Score: 0.025
-
Blanco JCG, Pletneva LM, McGinnes-Cullen L, Otoa RO, Patel MC, Fernando LR, Boukhvalova MS, Morrison TG. Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model. Nat Commun. 2018 05 15; 9(1):1904.
Score: 0.023
-
Cullen LM, Blanco JC, Morrison TG. Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein. J Transl Med. 2015 Nov 05; 13:350.
Score: 0.019
-
Morrison TG. Protein conformation in a vaccine matters. Oncotarget. 2015 Sep 08; 6(26):21781-2.
Score: 0.019
-
Morrison TG. Meeting report VLPNPV: Session 3: Immune responses. Hum Vaccin Immunother. 2014; 10(10):3064-7.
Score: 0.017
-
Morrison TG, Walsh EE. Subunit and virus-like particle vaccine approaches for respiratory syncytial virus. Curr Top Microbiol Immunol. 2013; 372:285-306.
Score: 0.016
-
McGinnes LW, Gravel KA, Finberg RW, Kurt-Jones EA, Massare MJ, Smith G, Schmidt MR, Morrison TG. Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins. J Virol. 2011 Jan; 85(1):366-77.
Score: 0.014
-
Murawski MR, McGinnes LW, Finberg RW, Kurt-Jones EA, Massare MJ, Smith G, Heaton PM, Fraire AE, Morrison TG. Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology. J Virol. 2010 Jan; 84(2):1110-23.
Score: 0.013
-
Laliberte JP, McGinnes LW, Morrison TG. Incorporation of functional HN-F glycoprotein-containing complexes into newcastle disease virus is dependent on cholesterol and membrane lipid raft integrity. J Virol. 2007 Oct; 81(19):10636-48.
Score: 0.011
-
Morrison TG. The three faces of paramyxovirus attachment proteins. Trends Microbiol. 2001 Mar; 9(3):103-5.
Score: 0.007
-
Blanco JCG, Boukhvalova MS, Morrison TG, Vogel SN. A multifaceted approach to RSV vaccination. Hum Vaccin Immunother. 2018 07 03; 14(7):1734-1745.
Score: 0.006
-
Ogembo JG, Muraswki MR, McGinnes LW, Parcharidou A, Sutiwisesak R, Tison T, Avendano J, Agnani D, Finberg RW, Morrison TG, Fingeroth JD. A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice. J Transl Med. 2015 Feb 06; 13:50.
Score: 0.005